BRAF and melanoma: Furthermore, an increase of autophagy levels was found in melanoma biopsies from patients treated with either a BRAF inhibitor alone or in combination with a MEK inhibitor in comparison to the levels measured before initiating treatment; this upregulation of autophagy was further associated with a lower progression-free survival time [70,71].